Troutman Pepper advised TELA Bio on the deal. TELA Bio announced the closing of its previously announced underwritten public offering of 4,600,000 shares of its common...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here